Semi-Annual Consolidated Balance Sheet

KAKEN PHARMACEUTIAL CO., LTD. - Filing #7721245

Concept As at
2018-06-30
As at
2018-03-31
Semi-annual consolidated balance sheet
Balance sheet
Assets
Current assets
Cash and deposits
40,555,000,000 JPY
45,095,000,000 JPY
Securities
7,599,000,000 JPY
7,599,000,000 JPY
Other
1,010,000,000 JPY
1,197,000,000 JPY
Allowance for doubtful accounts
0 JPY
JPY
Current assets
99,437,000,000 JPY
103,859,000,000 JPY
Non-current assets
Property, plant and equipment
26,454,000,000 JPY
26,141,000,000 JPY
Property, plant and equipment
Buildings and structures
Buildings and structures, net
17,173,000,000 JPY
17,274,000,000 JPY
Other
Other, net
9,281,000,000 JPY
8,866,000,000 JPY
Intangible assets
Intangible assets
531,000,000 JPY
552,000,000 JPY
Investments and other assets
22,339,000,000 JPY
21,863,000,000 JPY
Investments and other assets
Investment securities
18,678,000,000 JPY
18,488,000,000 JPY
Other
3,661,000,000 JPY
3,375,000,000 JPY
Non-current assets
49,326,000,000 JPY
48,557,000,000 JPY
Assets
148,763,000,000 JPY
152,417,000,000 JPY
Liabilities
Current liabilities
Notes and accounts payable - trade
11,225,000,000 JPY
12,204,000,000 JPY
Short-term borrowings
3,875,000,000 JPY
3,875,000,000 JPY
Income taxes payable
2,069,000,000 JPY
5,097,000,000 JPY
Other
8,636,000,000 JPY
7,289,000,000 JPY
Current liabilities
28,933,000,000 JPY
31,401,000,000 JPY
Non-current liabilities
Retirement benefit liability
6,612,000,000 JPY
6,787,000,000 JPY
Other
702,000,000 JPY
354,000,000 JPY
Non-current liabilities
7,315,000,000 JPY
7,141,000,000 JPY
Liabilities
36,249,000,000 JPY
38,543,000,000 JPY
Provision for bonuses
594,000,000 JPY
1,242,000,000 JPY
Net assets
Share capital
23,853,000,000 JPY
23,853,000,000 JPY
Shareholders' equity
Capital surplus
11,408,000,000 JPY
11,408,000,000 JPY
Retained earnings
98,296,000,000 JPY
97,284,000,000 JPY
Treasury shares
-25,828,000,000 JPY
-23,259,000,000 JPY
Shareholders' equity
107,729,000,000 JPY
109,287,000,000 JPY
Valuation and translation adjustments
Valuation difference on available-for-sale securities
5,642,000,000 JPY
5,510,000,000 JPY
Remeasurements of defined benefit plans
-857,000,000 JPY
-923,000,000 JPY
Valuation and translation adjustments
4,784,000,000 JPY
4,587,000,000 JPY
Net assets
112,514,000,000 JPY
113,874,000,000 JPY
Liabilities and net assets
148,763,000,000 JPY
152,417,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.